Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

October 28, 2019October 30, 2019

Trabectedin, Bevacizumab, Platinum Chemotherapy Combo May Work, But Safety a Concern, Study Finds

News

Women with ovarian cancer who are partially sensitive to platinum-based chemotherapy may benefit from a new combination therapy — but safety concerns need to be addressed first, a study suggests. ... Read more

October 23, 2019

New Microscope Technique Improves Metastasis Detection in Ovarian Cancer Patients

News

A newly developed imaging approach that combines laser microscopy with computational analysis may make it easier to spot ovarian cancer cells that have spread to other organs, called metastasis, a ... Read more

September 30, 2019October 16, 2019

Fertility-Sparing Surgery Equally Effective as Radical Surgery in Early Stage Ovarian Cancer, Study Finds

News

Surgical treatment aimed at preserving fertility is just as effective, in terms of survival, as more aggressive surgery in treating early-stage ovarian cancer, a new study suggests. The study, “Fertility-sparing ... Read more

September 9, 2019

Assay Shows Potential in Predicting Ovarian Cancer Response to Chemotherapy

News

A new assay that grows patients’ cancer tissue in the lab and tests for treatment sensitivity may be able to spot ovarian cancer patients likely to respond best to first-line ... Read more

August 19, 2019

Survival Benefits of High-Volume Ovarian Cancer Surgery Centers Come at Accessibility Cost, Study Says

News

Hospitals that perform many ovarian cancer surgeries tend to have better treatment outcomes in terms of mortality, a study suggests. But restricting this surgery to only high-volume hospitals would greatly ... Read more

August 7, 2019

Pre-cancerous Lesions Do Not Always Lead to Ovarian Cancer, Study Finds

News

Not all “pre-cancerous” ovarian lesions progress to full-fledged cancer, a new study reports. If confirmed, these results could allow for better identification of ovarian cancer at its very early stages, ... Read more

June 7, 2019

Immune Checkpoint Molecules Have Prognostic Value in Ovarian Cancer, Study Reports

News

The immune checkpoint molecules PD-L1 and TIM-3 have prognostic value in people with ovarian cancer who have not yet received chemotherapy. But while low levels of TIM-3 were linked to ... Read more

March 15, 2019March 15, 2019

Ultrasensitive Chip Detects Cancer Faster, Less Invasively than Current Approaches, Study Suggests

News

Researchers have developed an ultrasensitive diagnostic device, a kind of “lab-on-a-chip,” that quickly detects cancer using a droplet of blood, potentially allowing for an easier, cheaper, and more timely cancer diagnosis. ... Read more

March 13, 2019March 13, 2019

Researchers Find Compounds that Kill Chemo-resistant Cancer Cells

News

A new study reports the development of compounds that could be used as ovarian cancer treatment. These compounds are particularly promising because they may be able to affect cancer that ... Read more

February 25, 2019

Artificial Intelligence May Predict Cancer Survival Better Than Current Methods, Study Suggests

News

Using diagnostic images, artificial intelligence is better able to predict ovarian cancer survival than other current prognostic methods, a study suggests. The study, “A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images ... Read more